Surgery of borderline tumors of the ovary: retrospective comparison of short-term outcome after laparoscopy or laparotomy

被引:30
作者
Odegaard, Elin
Staff, Anne Cathrine
Langebrekke, Anton
Engh, Vibeke
Onsrud, Mathias
机构
[1] Ullevaal Univ Hosp, Dept Obstet & Gynecol, N-0450 Oslo, Norway
[2] Ullevaal Univ Hosp, Dept Pathol, N-0450 Oslo, Norway
[3] Univ Oslo, Fac Med, Oslo, Norway
关键词
ovarian neoplasms; laparoscopy; laparotomy; complications; FROZEN-SECTION; MANAGEMENT; SURVIVAL; RUPTURE; CANCER; CAPSULE;
D O I
10.1080/00016340701286934
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background. Laparoscopic management of borderline ovarian tumors is controversial. Objective. To retrospectively compare outcome after surgery by laparoscopy or laparotomy for borderline tumors. Methods. Ovarian tumors from all women operated at Ulleval University Hospital during a five-year period were re-evaluated histologically. Patients with borderline FIGO (International Federation of Gynaecology and Obstetrics) stage I tumors were retrospectively compared regarding surgery outcome following laparoscopy or laparotomy. Results. Histological re-evaluation revealed only 3 misclassifications in 608 patients. Borderline tumors represented 36% of epithelial ovarian malignancies. The 107 borderline stage I included 52 serous, 53 mucinous, and 2 endometrioid tumors. Thirty-eight patients were operated on primarily by laparoscopy and 69 by laparotomy (including 14 women starting with laparoscopy). In the laparoscopy group, more women were premenopausal (63% versus 35%, p = 0.01) and median tumor diameter was smaller (8.6 versus 16.4 cm, p < 0.001) as compared to the laparotomy group. When tumor diameter exceeded 10 cm, intraoperative tumor rupture was significantly more frequent during laparoscopy than during laparotomy (p = 0.01). Less postoperative complications were seen after laparoscopic operations (p = 0.034), but laparoscopic surgeries were less extensive, without hysterectomy, as compared to laparotomy. During the 14-78 months follow-up time, no relapse occurred in either group. After fertility-sparing surgery, there was no statistical significant difference regarding successful pregnancies between the two groups. Conclusions. Laparoscopic treatment of borderline ovarian tumors is feasible if tumor is of moderate size (diameter below 10 cm), gives fewer complications, and shorter hospital stay. Long-term follow-up of larger materials is needed to determine the ultimate recurrence risk as well as fertility rates.
引用
收藏
页码:620 / 626
页数:7
相关论文
共 26 条
[1]   OVARIAN-CANCER SPREAD - IS LAPAROSCOPY TO BLAME [J].
BEREK, JS .
LANCET, 1995, 346 (8969) :200-200
[2]   Clinical outcome after laparoscopic pure management of borderline ovarian tumors:: results of a series of 34 patients [J].
Camatte, S ;
Morice, P ;
Atallah, D ;
Thoury, A ;
Pautier, R ;
Lhommé, C ;
Duvillard, P ;
Castaigne, D .
ANNALS OF ONCOLOGY, 2004, 15 (04) :605-609
[3]   Frozen section in laparoscopic management of macroscopically suspicious ovarian masses [J].
Canis, M ;
Mashiach, R ;
Wattiez, A ;
Botchorishvili, R ;
Rabischong, B ;
Jardon, K ;
Safi, A ;
Pouly, JL ;
Déchelotte, P ;
Mage, G .
JOURNAL OF THE AMERICAN ASSOCIATION OF GYNECOLOGIC LAPAROSCOPISTS, 2004, 11 (03) :365-369
[4]  
DEMBO AJ, 1990, OBSTET GYNECOL, V75, P263
[5]   Laparoscopic management of borderline ovarian tumors:: results of a French multicenter study [J].
Fauvet, R ;
Boccara, J ;
Dufournet, C ;
Poncelet, C ;
Daraï, E .
ANNALS OF ONCOLOGY, 2005, 16 (03) :403-410
[6]   Diagnostic accuracy of frozen section diagnosis of the adnexal mass: a metaanalysis [J].
Geomini, P ;
Bremer, G ;
Kruitwagen, R ;
Mol, BWJ .
GYNECOLOGIC ONCOLOGY, 2005, 96 (01) :1-9
[7]  
KAERN J, 1993, CANCER, V71, P1810, DOI 10.1002/1097-0142(19930301)71:5<1810::AID-CNCR2820710516>3.0.CO
[8]  
2-V
[9]  
Lee KR., 2003, Pathology and Genetics of Tumors of the Breast and Female Genital Organs, P113
[10]   Are borderline tumors of the ovary safely treated by laparoscopy? [J].
Maneo, A ;
Vignali, M ;
Chiari, S ;
Colombo, A ;
Mangioni, C ;
Landoni, F .
GYNECOLOGIC ONCOLOGY, 2004, 94 (02) :387-392